J E Toblli Selected Research

J E Toblli Research Topics

5	Fibrosis (Cirrhosis) 10/2006 - 01/2001
3	Proteinuria 01/2017 - 11/2005
3	Hypertension (High Blood Pressure) 11/2005 - 06/2000
2	Hypernatremia 11/2016 - 04/2015
2	Inflammation (Inflammations) 04/2015 - 10/2006
2	Atrophy 07/2001 - 01/2001
1	Body Weight (Weight, Body) 07/2015
1	Hypoxia (Hypoxemia) 04/2015
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 02/2012
1	Kidney Diseases (Kidney Disease) 11/2007
1	Mitochondrial Diseases (Mitochondrial Disease) 11/2005
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2005
1	Hyperoxaluria (Oxaluria) 07/2001
1	Albuminuria 01/2001
1	Nephrolithiasis 01/2001
1	Erectile Dysfunction 06/2000

4	CreatinineIBA 01/2017 - 01/2001
3	SodiumIBA 11/2016 - 10/2006
2	AlbuminsIBA 01/2017 - 07/2001
2	tempolIBA 11/2016 - 04/2015
2	Angiotensin IIIBA 04/2015 - 11/2005
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2005 - 07/2001
2	Transforming Growth Factor beta (TGF-beta)IBA 06/2003 - 07/2001
1	iron isomaltoside 1000IBA 07/2015
1	IronIBA 07/2015
1	Ferrosoferric Oxide (Magnetite)FDA Link 07/2015
1	Dextrans (Dextran)FDA Link 07/2015
1	Caspase 3 (Caspase-3)IBA 07/2015
1	Tyrosine (L-Tyrosine)FDA Link 07/2015
1	ferric carboxymaltoseIBA 07/2015
1	Saccharated Ferric Oxide (Venofer)FDA Link 07/2015
1	Losartan (Cozaar)FDA LinkGeneric 04/2015
1	Atrial Natriuretic Factor (ANF)IBA 04/2015
1	teferrolIBA 02/2012
1	Proteins (Proteins, Gene)FDA Link 11/2007
1	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 11/2007
1	Oxidants (Oxidizing Agents)IBA 11/2005
1	candesartanIBA 11/2005
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2005
1	Plasminogen Activator Inhibitor 1IBA 01/2005
1	Perindopril FDA LinkGeneric 01/2005
1	CollagenIBA 01/2005
1	candesartan cilexetil (Amias)FDA Link 08/2004
1	Enalapril FDA LinkGeneric 07/2001
1	Ethylene Glycol (Monoethylene Glycol)IBA 07/2001
1	OxalatesIBA 07/2001
1	Uric Acid (Urate)IBA 01/2001
1	CalciumIBA 01/2001
1	Potassium Citrate FDA LinkGeneric 01/2001
1	Antihypertensive Agents (Antihypertensives)IBA 06/2000

2	Therapeutics 01/2001 - 06/2000